Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome.

Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen in hospitals. Current antimicrobial regimens for eradicating colonizing strains are not well defined and are often complicated by the emergence of resistance. The combination of novobiocin plus rifampin in vitro and in vivo was f...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Walsh, T J, Standiford, H C, Reboli, A C, John, J F, Mulligan, M E, Ribner, B S, Montgomerie, J Z, Goetz, M B, Mayhall, C G, Rimland, D
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187962/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8328783/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.6.1334
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!